Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
DOKTER STRICKAERT KELLY, PNEUMOLOGIE – ONCOLOGIE from Zwalm, company number BE0678423542, closed financial year 2025 with a result of € 385,000 after tax. For that financial year DOKTER STRICKAERT KELLY, PNEUMOLOGIE – ONCOLOGIE recorded a gross margin of € 535,249 and equity of € 490,358. Compared with financial year 2024, the result moved from € 232,532 to € 385,000. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.
€ 490,358
▲ 8% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 385,000
▲ 66% vs 2024
Profit after tax over the fiscal year.
€ 233,007
▲ 40% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 350,000 paid out
91 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 36
▼ 91% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,140
▲ 6% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 5,830
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 205,837 | € 130,867 | € 329,095 | € 535,249 | ▲ 63% |
| Profit after taxes | € 133,181 | € 80,172 | € 232,532 | € 385,000 | ▲ 66% |
| Equity | € 442,654 | € 522,826 | € 455,358 | € 490,358 | ▲ 8% |
| Total debts | € 87,686 | € 51,302 | € 14,245 | € 14,365 | ▲ 1% |
| Cash | € 384,182 | € 404,095 | € 166,969 | € 233,007 | ▲ 40% |
| Retained profit | € 424,054 | € 504,226 | € 436,758 | € 471,758 | ▲ 8% |
| Dividend | € 0 | € 0 | € 300,000 | € 350,000 | ▲ 17% |
| Bank debt | € 74,615 | € 35,967 | € 0 | € 0 | |
| Balance sheet total | € 530,340 | € 574,127 | € 469,603 | € 504,722 | ▲ 7% |
Key figures of DOKTER STRICKAERT KELLY, PNEUMOLOGIE – ONCOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DOKTER STRICKAERT KELLY, PNEUMOLOGIE – ONCOLOGIE?
What happened at DOKTER STRICKAERT KELLY, PNEUMOLOGIE – ONCOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 385,000 (▲ 66% vs 2024). Source: NBB ↗
- New establishment in Zwalm. KBO
- Start of the company according to the CBE. KBO
In short
From € 133,181 profit in 2022 to € 385,000 profit in 2025.
Paid € 255,536 in corporate taxes since 2022.
Best year ever: 2025, with € 385,000 profit.
Paid out € 650,000 in dividends to the owners in total.
Management
Behind DOKTER STRICKAERT KELLY, PNEUMOLOGIE – ONCOLOGIE is Kelly Strickaert.
Directors
According to the 2025 annual accounts
Kelly Strickaert
Director
Establishments
Establishment units
Physical locations of this company
Dries(SML) 12
9630 Zwalm
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0678.423.542
- VAT number
- BE 0678.423.542
- Registered office
- Dries(SML) 12, 9630 Zwalm
- Names & denominations
- DOKTER STRICKAERT KELLY, PNEUMOLOGIE – ONCOLOGIE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 July 2017
- Peppol
- Not registered